Ekaterina Bayurova
Overview
Explore the profile of Ekaterina Bayurova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kostyusheva A, Brezgin S, Ponomareva N, Frolova A, Lunin A, Bayurova E, et al.
Mol Ther
. 2024 Nov;
33(1):168-183.
PMID: 39511888
The demand for RNA-based therapeutics is increasing globally. However, their use is hampered by the lack of safe and effective delivery vehicles. Here, we developed technologies for highly efficient delivery...
2.
Brezgin S, Frolova A, Bayurova E, Slatinskaya O, Ponomareva N, Parshina E, et al.
Anal Chem
. 2024 Oct;
96(43):17432-17443.
PMID: 39402710
Extracellular vesicles (EVs), biomimetics, and other biological nanoparticles (BNs) produced from human cells are gaining increasing attention in the fields of molecular diagnostics and nanomedicine for the delivery of therapeutic...
3.
Ponomareva N, Brezgin S, Karandashov I, Kostyusheva A, Demina P, Slatinskaya O, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794330
Biological nanoparticles (NPs), such as extracellular vesicles (EVs), exosome-mimetic nanovesicles (EMNVs) and nanoghosts (NGs), are perspective non-viral delivery vehicles for all types of therapeutic cargo. Biological NPs are renowned for...
4.
Zhitkevich A, Bayurova E, Avdoshina D, Zakirova N, Frolova G, Chowdhury S, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675996
Author Juris Jansons requested his exclusion from the authors of the original publication [...].
5.
Zhitkevich A, Bayurova E, Avdoshina D, Zakirova N, Frolova G, Chowdhury S, et al.
Viruses
. 2024 Feb;
16(2).
PMID: 38399969
The high incidence of epithelial malignancies in HIV-1 infected individuals is associated with co-infection with oncogenic viruses, such as high-risk human papillomaviruses (HR HPVs), mostly HPV16. The molecular mechanisms underlying...
6.
Bayurova E, Zhitkevich A, Avdoshina D, Kupriyanova N, Kolyako Y, Kostyushev D, et al.
Cells
. 2023 Aug;
12(16).
PMID: 37626830
Common marmosets (; CMs) are small New World primates widely used in biomedical research. Early stages of such research often include in vitro experiments which require standardized and well-characterized CM...
7.
Kostyushev D, Brezgin S, Kostyusheva A, Ponomareva N, Bayurova E, Zakirova N, et al.
Mol Ther Nucleic Acids
. 2023 May;
32:478-493.
PMID: 37187708
APOBEC/AID cytidine deaminases play an important role in innate immunity and antiviral defenses and were shown to suppress hepatitis B virus (HBV) replication by deaminating and destroying the major form...
8.
Kostyushev D, Kostyusheva A, Brezgin S, Ponomareva N, Zakirova N, Egorshina A, et al.
Mol Ther Nucleic Acids
. 2023 Mar;
31:482-493.
PMID: 36865089
CRISPR-Cas9 systems can directly target the hepatitis B virus (HBV) major genomic form, covalently closed circular DNA (cccDNA), for decay and demonstrate remarkable anti-HBV activity. Here, we demonstrate that CRISPR-Cas9-mediated...
9.
Brezgin S, Kostyusheva A, Ponomareva N, Bayurova E, Kondrashova A, Frolova A, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839856
Because of their high biocompatibility, biological barrier negotiation, and functionalization properties, biological nanoparticles have been actively investigated for many medical applications. Biological nanoparticles, including natural extracellular vesicles (EVs) and synthetic...
10.
Petkov S, Kilpelainen A, Bayurova E, Latanova A, Mezale D, Fridrihsone I, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612231
DNA immunization with HIV-1 protease (PR) is advanced for immunotherapy of HIV-1 infection to reduce the number of infected cells producing drug-resistant virus. A consensus PR of the HIV-1 FSU_A...